Castleark Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,240
| Closed | -$196K | – | 339 |
|
|
2020
Q4 | $196K | Hold |
2,240
| – | – | 0.01% | 308 |
|
|
2020
Q3 | $170K | Sell |
2,240
-3,060
| -58% | -$232K | 0.01% | 313 |
|
|
2020
Q2 | $654K | Buy |
5,300
+3,190
| +151% | +$394K | 0.03% | 237 |
|
|
2020
Q1 | $178K | Buy |
+2,110
| New | +$178K | 0.01% | 284 |
|
|
2015
Q3 | – | Sell |
-38,250
| Closed | -$5.23M | – | 369 |
|
|
2015
Q2 | $5.23M | Buy |
38,250
+2,250
| +6% | +$308K | 0.14% | 179 |
|
|
2015
Q1 | $4.49M | Sell |
36,000
-2,150
| -6% | -$268K | 0.11% | 206 |
|
|
2014
Q4 | $3.45M | Buy |
+38,150
| New | +$3.45M | 0.09% | 190 |
|
|
2013
Q3 | – | Sell |
-1,125
| Closed | -$63K | – | 351 |
|
|
2013
Q2 | $63K | Buy |
+1,125
| New | +$63K | ﹤0.01% | 310 |
|